Cyfuse Biomedical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 22

Employees

  • Stock Symbol
  • 4892

Stock Symbol

  • Share Price
  • $5.00
  • (As of Friday Closing)

Cyfuse Biomedical General Information

Description

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Stock Exchange
TKS
Corporate Office
  • 1F Sumitomo Real Estate Mita Twin Building West Wing
  • 3-5-27 Mita, Minato-ku
  • Tokyo, 108-6301
  • Japan
+81 00-0000-0000

Cyfuse Biomedical Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyfuse Biomedical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.00 $4.93 $4.31 - $7.52 $40.7M 8.13M 118K -$0.57

Cyfuse Biomedical Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 17,242 21,876 57,078
Revenue 448 435 2,850 6,450
EBITDA (3,831) (2,966) 1,534
Net Income (4,467) (4,193) (3,607) 1,301
Total Assets 25,793 29,886 36,725 22,997
Total Debt 5,342 6,474 6,926 4,945
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cyfuse Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Discovery Tools (Healthcare)
Tokyo, Japan
22 As of 2023
000.00
000.00 0000-00-00
00000000 000.00

00000

se cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000000
Basel, Switzerland
00000 As of 0000
00000
000000000000 00000

00 000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
000000000 00000 (000
Bridgewater, NJ
0 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyfuse Biomedical Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lonza Group Corporation Basel, Switzerland 00000 00000 000000000000 00000
3D Biotek Corporate Backed or Acquired Bridgewater, NJ 0 000000&0
Sutro Biopharma Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
Teva Pharmaceutical Industries Corporation Tel Aviv, Israel 00000 000.00 000000000 000.00
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 000 000.00 0000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Cyfuse Biomedical Patents

Cyfuse Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023035224-A Tubular skin culture Pending 31-Aug-2021
EP-3896429-A4 Quality evaluation method Pending 10-Dec-2019
JP-2020202785-A Three-dimensional cell structure and method for producing the same Pending 17-Jun-2019
US-20220331483-A1 Nerve regeneration inducing material Pending 16-May-2019 00000000000
US-20220315899-A1 Human liver-like three-dimensional structure, method for evaluating hepatotoxicity and human liver-like complex Pending 22-Feb-2019 C12N5/067
To view Cyfuse Biomedical’s complete patent history, request access »

Cyfuse Biomedical Executive Team (8)

Name Title Board Seat Contact Info
Shizuka Akieda Chief Executive Officer & Board Member
Masahiro Sanjo Chief Financial Officer, Board Member & Head of Corporate Planning and Business Administration
Norihiko Tokunaga Director, System Development Department
Yoichi Oda Outside Audit & Supervisory Board Member
Koichi Nakayama Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Cyfuse Biomedical Board Members (11)

Name Representing Role Since
000000 0000000 Self External Audit & Supervisory Board Member 000 0000
00000000 000000 Cyfuse Biomedical Outside Director 000 0000
00000000 00000 Cyfuse Biomedical Chief Financial Officer, Board Member & Head of Corporate Planning and Business Administration 000 0000
0000000 000000 Cyfuse Biomedical Chief Executive Officer & Board Member 000 0000
00000 000000 Self External Audit & Supervisory Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Cyfuse Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyfuse Biomedical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical FAQs

  • When was Cyfuse Biomedical founded?

    Cyfuse Biomedical was founded in 2010.

  • Who is the founder of Cyfuse Biomedical?

    Koichi Nakayama Ph.D and Koji Kuchiishi are the founders of Cyfuse Biomedical.

  • Who is the CEO of Cyfuse Biomedical?

    Shizuka Akieda is the CEO of Cyfuse Biomedical.

  • Where is Cyfuse Biomedical headquartered?

    Cyfuse Biomedical is headquartered in Tokyo, Japan.

  • What is the size of Cyfuse Biomedical?

    Cyfuse Biomedical has 22 total employees.

  • What industry is Cyfuse Biomedical in?

    Cyfuse Biomedical’s primary industry is Discovery Tools (Healthcare).

  • Is Cyfuse Biomedical a private or public company?

    Cyfuse Biomedical is a Public company.

  • What is Cyfuse Biomedical’s stock symbol?

    The ticker symbol for Cyfuse Biomedical is 4892.

  • What is the current stock price of Cyfuse Biomedical?

    As of 12-Jul-2024 the stock price of Cyfuse Biomedical is $5.00.

  • What is the current market cap of Cyfuse Biomedical?

    The current market capitalization of Cyfuse Biomedical is $40.7M.

  • What is Cyfuse Biomedical’s current revenue?

    The trailing twelve month revenue for Cyfuse Biomedical is $448K.

  • Who are Cyfuse Biomedical’s competitors?

    Lonza Group, 3D Biotek, Sutro Biopharma, Teva Pharmaceutical Industries, and Aspect Biosystems are some of the 9 competitors of Cyfuse Biomedical.

  • What is Cyfuse Biomedical’s annual earnings per share (EPS)?

    Cyfuse Biomedical’s EPS for 12 months was -$0.57.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »